Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
6
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
medicare
6
×
national
national blog main
national top stories
new york blog main
6
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
deals
novartis
biogen
cancer
clinical trials
eli lilly
fda
gene therapy
merck
pfizer
startups
What
bio
roundup
drug
patients
terms
acquisitions
administration
advantages
albert
alzheimer’s
angry
anti
appetite
bar
becker
benefited
biggest
billions
black
bourla
bread
brings
butter
buyout
cancer
cash
ceo
company
congress
crispr
democrats
despite
diabetes
diamond’s
divided
dollars
drugs
eaton
elections
eli
Language
unknown
unset
Current search:
medicare
×
" new york blog main "
×
amgen
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel